Newsletter

BioMedSA’s Board of Directors approved 4 new memberships in June 2024: Eppendorf, Lone Star National Bank, Pizarro Allen, and Raven Innovations. Eppendorf is a German based company that seeks to support research in academic, commercial, and industrial spaces by developing and manufacturing a variety of products and services for use in laboratories in pharmaceutical, biotech, … Read more

Dr. Alison Wiesenthal is the current Chair of the Department of Rehabilitation Medicine at Brooke Army Medical Center (BAMC). Stepping into this role in March of 2020, Wiesenthal became the first civilian to hold the position. She founded the first interdisciplinary Palliative Care Service to the Department of Defense in 2017. Her current role also … Read more

Dr. Laurence Morel is investigating the mechanisms of lupus pathogenesis. The ultimate goal of her work is to establish better clinical management and therapeutic targets by identifying lupus susceptibility in genes or pathways.  Her current focus is CD4 T cells and B cells. In 2022, the University of Texas System awarded Dr. Morel $1.4M to establish … Read more

BioMedSA’s Board of Directors approved 3 new memberships in April 2024: GoldiloxBio, Maribel Gonzalez and TECHspace. GoldiloxBio develops novel assays to provide predictive pre-clinical toxicity and efficacy testing to the BioPharma market. Maribel Gonzalez is the Co-Founder and Owner of Vitality Chronic Care Management as well as a leader in the development of Platelet-Rich Plasma … Read more

  After a rigorous application and acceptance process, pitch development support and in-person pitching, the Biofest Invest 2024 winner is NeuraStasis, as startup.  NeuraStasis seeks to improve health outcomes for stroke survivors through the use of neurostimulation. The Houston startup was founded in 2021 by Dr. Kirt Gill and Joe Upchurch in an effort to … Read more

Biofest Days was a week-long celebration of the Healthcare and Bioscience industry held from April 16-April 20 that highlighted the assets and support structure of a thriving and growing ecosystem. Centering around the Biofest Invest startup conference and pitch competition, BioMedSA extended the invitation to local, regional, and national organizations to participate in Biofest Days … Read more

BioMedSA’s Board of Directors approved 2 new memberships in February 2024: ALS Association and Capital Factory Established in 1985, the ALS Association (Amyotrophic Lateral Sclerosis Association) is the only national nonprofit organization fighting ALS on every front. Seeking to lead the way in global research, providing assistance for people with ALS, coordinating multidisciplinary care through … Read more

Partnering with large and mid-sized biopharma companies is a key part of the journey for biotech companies looking to develop, market, or deploy new assets and medical interventions. Whether it’s to gain access to experts, funding, facilities, or industry knowledge, you first need to get on a partner’s radar.   The art and science of success … Read more

One tier of the BioMedSA mission is to support the regional healthcare and bioscience ecosystem. One of the ways we do that is to highlight the community assets that available to support the needs of innovators.  Below is a collection of lab space assets that are available… Alamo BioCenter is a new flexible coworking laboratory … Read more

BioMedSA’s Board of Directors approved 3 new memberships in February 2024: Denovo Innovations Group, Hogan Lovells, J.R. Stockton Consulting, and LCM Biosensor Technologies. Denovo Innovations Group works to transform modern healthcare through data science, data analytics and software solutions with a focus on collaborating and supporting early-stage startups that seek commercialization. Data solutions expertise ranges … Read more